David Mahvi to Antimetabolites, Antineoplastic
This is a "connection" page, showing publications David Mahvi has written about Antimetabolites, Antineoplastic.
Connection Strength
0.009
-
Phase I study of continuous-infusion L-S,R-buthionine sulfoximine with intravenous melphalan. J Natl Cancer Inst. 1997 Dec 03; 89(23):1789-96.
Score: 0.009